What is the controversy over the spinal muscular atrophy drug in Keralam? Explained
After the government switched the drug in its SMA programme from branded to generic, parents of children living with SMA have been asking for a switch back to the branded version; meanwhile the label on a drug bottle has sparked concerns, and political partie…
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
The HinduWhat is the controversy over the spinal muscular atrophy drug in Keralam? ExplainedThe HinduWhat is the controversy over the spinal muscular atrophy drug in Keralam? Explained9 recorded states
Signal first indexedP1 · 72% quality · 2 sources
Quality 72→76P1 · 76% quality · 2 sources
Quality 76→80P1 · 80% quality · 2 sources
Quality 80→84P1 · 84% quality · 2 sources
Quality 84→88P1 · 88% quality · 2 sources
Quality 88→92P1 · 92% quality · 2 sources
Quality 92→96P1 · 96% quality · 2 sources
Quality 96→99P1 · 99% quality · 2 sources
Headline updatedP1 · 99% quality · 2 sources